Study of roles of endogenous hydrogen sulfide in stomach with mucosal injury
Project/Area Number |
23590122
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | Kinki University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KAWABATA Atsufumi 近畿大学, 薬学部, 教授 (20177728)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 硫化水素合成酵素 / 胃癌細胞増殖 / T型カルシウムチャネル / 抗アポトーシス因子 / 胃粘膜傷害 / 細胞増殖 / アポトーシス / 酵素 / 細胞・組織 / シグナル伝達 |
Research Abstract |
In human gastric cancer-derived AGS cells, our findings suggest that endogenous hydrogen sulfide (H2S) produced by cystathionine-gamma-lyase (CSE), one of H2S-forming enzymes in the mammalian body, accelerates the proliferation of AGS cells. The effects of H2S may be mediated, in part, by increase in function of Cav3.2 T-type calcium channels and upregulation of anti-apoptotic proteins, Bcl-2 and Bcl-xL, via activation of NF-kappaB caused by endogenous H2S. These pathways can be expected to be effective targets for treatment of gastric cancer.
|
Report
(5 results)
Research Products
(11 results)